Immunoquantification of serum lipoprotein(a) in healthy Ivorian subject: A comparative evaluation of two methods;Valeurs sériques de la lipoprotéine(a) chez l'Ivoirien présumé sain: Étude comparée de deux méthodes de dosage immunochimiques

Annales de Biologie Clinique

Volumn 65, Issue 6, 2007, Pages 629-635

  Edjeme Ake, A ^a,b   Garnotel, R ^c,d   Angles Cano E ^e   Monnet, D ^a   Gillery, P ^c,d  

^a UNIVERSITÉ FÉLIX HOUPHOUËT BOIGNY   (Côte d’Ivoire)

^b INSTITUT PASTEUR DE CÔTE D'IVOIRE   (Côte d’Ivoire)

^c UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^d AMERICAN MEMORIAL HOSPITAL   (France)

^e UNIVERSITÉ DE CAEN   (France)

Author keywords

Electroimmunodiffusion; Healthy subjects; Immunonephelometry; Ivory Coast; Lipoprotein(a)

Indexed keywords

LIPOPROTEIN A;

ADOLESCENT; ADULT; ARTICLE; BLOOD; COTE D'IVOIRE; HUMAN; IMMUNOASSAY; IMMUNODIFFUSION; METHODOLOGY; MIDDLE AGED; PHOTOMETRY; REFERENCE VALUE; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; COTE D'IVOIRE; HUMANS; IMMUNOASSAY; IMMUNODIFFUSION; LIPOPROTEIN(A); MIDDLE AGED; NEPHELOMETRY AND TURBIDIMETRY; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 37049026679     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: 10.1684/abc.2007.0174     Document Type: Article

References (28)

1. Berg K. A new serum system in man. The LP system. Acta Pathol Microbiol Scand 1963 ; 59 : 369-82.
2. Lackner C, Cohen JC, Hobbs HH. Molecular definition of the extreme size polymorphism in apolipoprotein(a). Hum Mol Genet 1993 ; 2 : 933-40.
3. Boerwinkle E, Leffert CC, Lin J, Lackner C, Chiesa G, Hobbs HH. Apolipoprotein(a) gene accounts for greater than 90 % of the variation in plasma lipoprotein(a) concentrations. J Clin Invest 1992 ; 90 : 52-60.
4. Djurovic S, Berg K. Epidemiology of Lp(a) : its role in atherosclerotic/thrombotic disease. Clin Genet 1997 ; 52 : 281-92.
5. Enas EA, Chacko V, Senthilkumar A, Puthumana N, Mohan V. Elevated lipoprotein(a) : a genetic risk factor for premature vascular disease in people with and without standard risk factors. A review. Dis Mon 2006 ; 52 : 5-50.
6. Luc G, Bard JM, Arveiler D, et al. Prime Study Group. Lipoprotein(a) as a predictor of coronary heart disease : the PRIME study. Atherosclerosis 2002 ; 163 : 377-84.
7. Koschinsky ML. Lipoprotein(a) and the link between atherosclerosis and thrombosis. Can J Cardiol 2004 ; 20 (Suppl. B) : 37B-43B.
8. Gaw A, Boerwinkle E, Cohen JC, Hobbs HH. Comparative analysis of the Apo(a) gene, Apo(a) glycoprotein and plasma concentrations of Lp(a) in three ethnic groups. Evidence for no commun "nul" allele at the apo(a) locus. J Clin Invest 1994 ; 93 : 2526-34.
9. Marcovina SM, Albers JJ, Wijsman E, Zhang Z, Chapman NH, Kennedy H. Differences in Lp(a) concentrations and Apo(a) polymorphs between black and white Americans. J Lip Res 1996 ; 37 : 2569-85.
10. Monnet D, Edjeme NE, Ndri K, et al. La lipoprotéine(a) et les protéines de la phase aiguë de l'inflammation au cours de la crise drépanocytaire homozygote. Ann Biol Clin (Paris) 2002 ; 60 : 101-3.
11. Schmidt K, Kraft HG, Parson W, Utermann G. Genetics of the Lp(a)/Apo(a) system in autochthonous black African population from the Gabon. Eur J Hum Genet 2006 ; 14 : 190-201.
12. Fellat S, Lahfidi K, Srairi JE, et al. Expérience de dosage de la lipoprotéine(a) dans une population marocaine de 184 sujets. Arch Mal Coeur Vaiss 1997 ; 90 : 1371-6.
13. Ngangoue N. Lipoprotéine(a) chez les donneurs de sang congolais. Eurobiologiste 1995 ; 29 : 249-52.
14. Marcovina SM, Albers JJ, Gabel B, Koschinsky ML, Gaur VP. Effect of the number of apolipoprotein(a) kringle 4 domains on immunochemical measurements of lipoprotein(a). Clin Chem 1995 ; 41 : 246-55.
15. Rifai N, Ma J, Sacks FM, et al. Apolipoprotein(a) size and lipoprotein(a) concentration and future risk of angina pectoris with evidence of severe coronary atherosclerosis in men : the Physician's Health Study. Clin Chem 2004 ; 50 : 1364-71.
16. Gillery P, Arthuis P, Cuperlier C, Circaud R. Rate nephelometric assay of serum lipoprotein(a). Clin Chem 1993 ; 39 : 503-8.
17. Laurell CB. Electroimmunoassay. Scand J Clin Lab Invest 1972 ; 124 : 21-37.
18. Angles-Cano E, Loyau S, Cardoso-Saldana G, Couderc R, Gillery P. A novel kringle-4 number-based recombinant apo(a) standard for human Lp(a) phenotyping. J Lipid Res 1999 ; 40 : 354-9.
19. Branchi A, Rovellini A, Arcangeli L, Bonini M, Torri A. Immunoquantification of lipoprotein(a) : a comparative evaluation of four methods. Paris : 11th International Symposium on Atherosclerosis, 1997.
20. Edelstein C, Hinman J, Marcovina S, Scanu AM. Properties of human free apolipoprotein(a) and lipoprotein(a) after either freezing or lyophilization in the presence and absence of cryopreservatives. Anal Biochem 2001 ; 288 : 201-8.
21. Tate JR, Rifai N, Berg K, et al. International Federation of Clinical Chemistry standardization project for the measurement of lipoprotein(a). Phase I. Evaluation of the analytical performance of lipoprotein assay system and commercial calibrators. Clin Chem 1998 ; 44 : 1629-40.
22. Marcovina SM, Albers JJ, Scanu AM, et al. Use of a reference material proposed by the International Federation of clinical Chemistry and laboratory Medecine to evaluate analytical methods for the determination of plasma lipoprotein(a). Clin Chem 2000 ; 46 : 1956-67.
23. Nguyen TT, Ellefson RD, Hodge DO, Bailey KR, Kottke TE, AbuLebdem HS. Predictive value of electrophoretically detected lipoprotein(a) for coronary heart disease and cerebrovascular disease in a community-based cohort of 9936 men and women. Circulation 1997 ; 96 : 1390-7.
24. Bostom AG, Gagnon DR, Cupples LA, et al. A prospective investigation of elevated Iipoprotein(a) detected by electrophoresis and cardiovascular disease in women : The Framingham Heart Study. Circulation 1994 ; 90 : 1688-95.
25. Ogorelkova M, Kraft HG, Ehnolm C, Utermann G. Single nucleotide polymorphisms in exons of apo(a) kringle IV type 6 to 10 domain affect Lp(a) plasma concentrations and have different pattern in Africans and Caucasians. Hum Mol Genet 2001 ; 10 : 815-24.
26. Scholtz M, Kraft HG, Lingenhel A, et al. Genetic control of lipoprotein(a) concentrations is different in Africans and Caucasians. Eur J Hum Genet 1999 ; 7 : 169-78.
27. Chrétien JP, Coresh J, Berthier-Schaad Y, et al. Three single-nucleotide polymorphism in LPA account for the increase of lipoprotein(a) level elevation in African Americans compared to European Americans. J Med Genet 2006 ; 43 : 917-23.
28. Dube N, Voorbij R, Leus F, Gomo ZA. Lipoprotein(a) concentrations and apolipoprotein(a) isoform distribution in Zimbabwean population. Cent Afr J Med 2002 ; 48 : 83-7.